Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1Phase 1 1

Status

Recruiting 3Active not recruiting 2

Sponsor Class

OTHER 2INDUSTRY 2NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5Thoracic 1

Conditions

Colorectal Neoplasms 5Neoplasm Metastasis 2Recurrence Free Survival 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Bevacizumab 25Fluorouracil 23Leucovorin 22Cetuximab 22Oxaliplatin 19pembrolizumab 14Specimen Handling 11Irinotecan 10Nivolumab 8Magnetic Resonance Spectroscopy 8Biopsy 7atezolizumab 6fludarabine 5encorafenib 5Pemetrexed 5Panitumumab 5HMPL-013 5Gemcitabine 5Folfox protocol 5Cisplatin 5Carboplatin 5trifluridine tipiracil drug combination 4balstilimab 4Standard of Care 4Immunoglobulin G 4Disulfides 4Cyclophosphamide 4regorafenib 3fludarabine phosphate 3dehydroftorafur 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Colorectal Neoplasms × Panitumumab × 30 days × Clear all
NCT05576896 2026-06-04

Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory

Northwestern University

Phase 2 Active not recruiting
7 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06820463 2026-06-02

AndroMETa-CRC

AbbVie

Phase 2 Recruiting
390 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT05863195 2026-06-01

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

Eastern Cooperative Oncology Group

Phase 3 Recruiting
408 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT04787341 2026-05-20

PARERE

Gruppo Oncologico del Nord-Ovest

Phase 2 Active not recruiting
214 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT07094204 2026-05-18

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Astellas Pharma Inc

Phase 1 Recruiting
364 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡